HLF - Herbalife Nutrition Ltd.
NYSE
->
Consumer Defensive
->
Packaged Foods
Los Angeles,
United States
Type: Equity
HLF price evolution
HLF
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $575.2 | $495.7 | $526.6 | $454.2 |
| Short term investments | ||||
| Net receivables | $81.2 | $79.5 | $86.3 | $85.1 |
| Inventory | $505.2 | $496.8 | $525.1 | $545.1 |
| Total current assets | $1399.3 | $1346.1 | $1371.4 | $1322.2 |
| Long term investments | ||||
| Property, plant & equipment | $692.3 | $683 | $686.3 | $681.9 |
| Goodwill & intangible assets | $409.4 | $407.2 | $409.2 | $409.2 |
| Total noncurrent assets | $1410.1 | $1378.6 | $1399.2 | $1365.4 |
| Total investments | ||||
| Total assets | $2809.4 | $2724.7 | $2770.6 | $2687.6 |
| Current liabilities | ||||
| Accounts payable | $84 | $77.9 | $88.6 | $67.9 |
| Deferred revenue | ||||
| Short long term debt | $309.5 | $232.6 | $295.8 | $293.7 |
| Total current liabilities | $1277.6 | $1165.4 | $1240.8 | $1227.2 |
| Long term debt | $2420.5 | $2493.2 | $2510.6 | $2521.9 |
| Total noncurrent liabilities | $2592.1 | $2662.8 | $2680.2 | $2683.2 |
| Total debt | $2730 | $2725.8 | $2806.4 | $2815.6 |
| Total liabilities | $3869.7 | $3828.2 | $3921 | $3910.4 |
| Shareholders' equity | ||||
| Retained earnings | -$1062.3 | -$1072.5 | -$1115.3 | -$1175.2 |
| Other shareholder equity | -$232 | -$253.1 | -$238 | -$239 |
| Total shareholder equity | -$1060.3 | -$1103.5 | -$1150.4 | -$1222.8 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $575.2 | $508 | $601.5 | $1045.4 |
| Short term investments | ||||
| Net receivables | $81.2 | $70.6 | $66.9 | $83.3 |
| Inventory | $505.2 | $580.7 | $575.7 | $501.4 |
| Total current assets | $1399.3 | $1356.1 | $1431.8 | $1775.8 |
| Long term investments | ||||
| Property, plant & equipment | $692.3 | $693.4 | $662.1 | $613 |
| Goodwill & intangible assets | $409.4 | $408.9 | $412.7 | $413.8 |
| Total noncurrent assets | $1410.1 | $1375.9 | $1388 | $1300.3 |
| Total investments | ||||
| Total assets | $2809.4 | $2732 | $2819.8 | $3076.1 |
| Current liabilities | ||||
| Accounts payable | $84 | $89.8 | $92 | $88.7 |
| Deferred revenue | ||||
| Short long term debt | $309.5 | $29.5 | $29.4 | $22.9 |
| Total current liabilities | $1277.6 | $976.6 | $1080.4 | $1127.3 |
| Long term debt | $2420.5 | $2662.5 | $2934.4 | $2612.2 |
| Total noncurrent liabilities | $2592.1 | $3021.3 | $3130.9 | $2804.9 |
| Total debt | $2730 | $2884.4 | $2963.8 | $2635.1 |
| Total liabilities | $3869.7 | $3997.9 | $4211.3 | $3932.2 |
| Shareholders' equity | ||||
| Retained earnings | -$1062.3 | -$1204.5 | -$1169 | -$687.4 |
| Other shareholder equity | -$232 | -$250.2 | -$211.8 | -$182.2 |
| Total shareholder equity | -$1060.3 | -$1265.9 | -$1391.5 | -$856.1 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1215 | $1281.3 | $1314 | $1252.1 |
| Cost of revenue | $287.6 | $303.2 | $301.6 | $298.6 |
| Gross Profit | $927.4 | $978.1 | $1012.4 | $953.5 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $474.3 | $455.3 | $460.5 | $475.9 |
| Total operating expenses | $871.6 | $871.4 | $889 | $883 |
| Operating income | $55.8 | $106.7 | $123.4 | $70.5 |
| Income from continuing operations | ||||
| EBIT | $67.3 | $107.7 | $123.4 | $70.5 |
| Income tax expense | $7.5 | $26.4 | $25.1 | $1.8 |
| Interest expense | $49.6 | $38.5 | $38.4 | $39.4 |
| Net income | ||||
| Net income | $10.2 | $42.8 | $59.9 | $29.3 |
| Income (for common shares) | $10.2 | $42.8 | $59.9 | $29.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5062.4 | $5204.4 | $5802.8 | $5541.8 |
| Cost of revenue | $1191 | $1173.6 | $1239.3 | $1150.6 |
| Gross Profit | $3871.4 | $4030.8 | $4563.5 | $4391.2 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1866 | $1810.4 | $2012.1 | $2075 |
| Total operating expenses | $3515 | $3485.6 | $3829.4 | $3750.6 |
| Operating income | $356.4 | $545.2 | $734.1 | $640.6 |
| Income from continuing operations | ||||
| EBIT | $368.9 | $564.1 | $713.9 | $649.4 |
| Income tax expense | $60.8 | $103.5 | $113.6 | $143.8 |
| Interest expense | $165.9 | $139.3 | $153.1 | $133 |
| Net income | ||||
| Net income | $142.2 | $321.3 | $447.2 | $372.6 |
| Income (for common shares) | $142.2 | $321.3 | $447.2 | $372.6 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $10.2 | $42.8 | $59.9 | $29.3 |
| Operating activities | ||||
| Depreciation | $28.2 | $28.4 | $29.1 | $27.6 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $12.3 | $13.7 | $11.2 | $10.8 |
| Total cash flows from operations | $96.1 | $79.6 | $135.6 | $46.2 |
| Investing activities | ||||
| Capital expenditures | -$35.3 | -$31.1 | -$38.3 | -$30.3 |
| Investments | ||||
| Total cash flows from investing | -$35.2 | -$31.1 | -$38.3 | -$30.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$1.3 | -$0.3 | -$0.7 | -$8.7 |
| Net borrowings | $8.7 | -$71.7 | -$9.8 | -$67.7 |
| Total cash flows from financing | $8.3 | -$71.3 | -$9.3 | -$76 |
| Effect of exchange rate | $10.3 | -$8.5 | -$2.5 | $5.5 |
| Change in cash and equivalents | $79.5 | -$31.3 | $85.5 | -$54.5 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $142.2 | $321.3 | $447.2 | $372.6 |
| Operating activities | ||||
| Depreciation | $113.3 | $115.4 | $107.6 | $100.3 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $48 | $44.4 | $54.1 | $51 |
| Total cash flows from operations | $357.5 | $352.5 | $460.3 | $628.6 |
| Investing activities | ||||
| Capital expenditures | -$135 | -$156.4 | -$151.4 | -$112 |
| Investments | ||||
| Total cash flows from investing | -$134.8 | -$156.2 | -$156.4 | -$123.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$11 | -$146.7 | -$1011.3 | -$923.5 |
| Net borrowings | -$140.5 | -$122.2 | $278.5 | $599.1 |
| Total cash flows from financing | -$148.3 | -$264.7 | -$728.6 | -$320.9 |
| Effect of exchange rate | $4.8 | -$25.7 | -$18.9 | $22 |
| Change in cash and equivalents | $79.2 | -$94.1 | -$443.6 | $206.5 |
News
Fundamentals
| Market cap | $912.64M |
|---|---|
| Enterprise value | $3.07B |
| Shares outstanding | 99.20M |
| Revenue | $5.06B |
|---|---|
| EBITDA | $482.20M |
| EBIT | $368.90M |
| Net Income | $142.20M |
| Revenue Q/Q | 2.90% |
| Revenue Y/Y | -2.73% |
| P/E ratio | 6.42 |
|---|---|
| EV/Sales | 0.61 |
| EV/EBITDA | 6.36 |
| EV/EBIT | 8.32 |
| P/S ratio | 0.18 |
| P/B ratio | -1.10 |
| Book/Share | -8.35 |
| Cash/Share | 5.80 |
| EPS | $1.43 |
|---|---|
| ROA | 5.17% |
| ROE | -12.54% |
| Debt/Equity | -3.65 |
|---|---|
| Net debt/EBITDA | 6.83 |
| Current ratio | 1.10 |
| Quick ratio | 0.70 |